Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic

Affiliations

¹ Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: matthias.guckenberger@usz.ch.
² Division of Radiation Oncology, Western University, London, Canada.

Comment

Matthias Guckenberger et al. Radiother Oncol. 2020 Jun.

. 2020 Jun:147:231.

doi: 10.1016/j.radonc.2020.04.049. Epub 2020 May 7.

¹ Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Switzerland. Electronic address: matthias.guckenberger@usz.ch.
² Division of Radiation Oncology, Western University, London, Canada.

No abstract available

Comment on

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Troost EGC, Nestle U, Putora PM, Bussink J. Troost EGC, et al. Radiother Oncol. 2020 Jun;147:227-228. doi: 10.1016/j.radonc.2020.04.030. Epub 2020 Apr 24. Radiother Oncol. 2020. PMID: 32342862 Free PMC article. No abstract available.
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic.
Magrini SM, Borghetti P, Filippi AR, Scorsetti M, Jereczek-Fossa BA, Corvò R, Arcangeli S, Vagge S, Russi E, Alongi F, Livi L, Buglione M. Magrini SM, et al. Radiother Oncol. 2020 Jun;147:229-230. doi: 10.1016/j.radonc.2020.04.034. Epub 2020 Apr 24. Radiother Oncol. 2020. PMID: 32342875 Free PMC article. No abstract available.

1. Troost, EGC. et al. Letter to the editor regarding Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2010;147:227–228. - PMC - PubMed
1. Magrini, SM. et al. Letter to the Editor. Radiother Oncol (in press).
1. Guckenberger, M. et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2010;146:223–229. - PMC - PubMed